News and Trends 24 Nov 2014
Will New Actavis-Allergan Entity Lead to Be in the World Top 10 Drugmakers Companies?
The US pharmaceutical company Allergan, known for their Botox, agreed an Actavis bid of 53 billion euros, they permanently passed up the proposition of Valeant Pharmaceuticals International and the activist investor William Ackman. The Allergan-Actavis entity will have a diversified portfolio of medicines and generic, especially in dermatology, gynecology and ophthalmology. It should generate about […]